<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240925063158N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-10-07</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>"The effect of phase III cardiac rehabilitation virtual training on the self-efficacy of patients after coronary artery bypass surgery"</public_title>
      <acronym></acronym>
      <scientific_title>"The effect of phase III cardiac rehabilitation virtual training on the self-efficacy of patients after coronary artery bypass surgery"</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-10-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/79259</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: The random sampling method is available and is done in the form of permutation blocks in two groups, Test and control, and at the time of discharge, The researcher introduced himself and the purpose of the study to the patients who have the conditions to enter this study. His companion states and if the patient wishes to participate in the study, Informed consent is obtained and the patient is placed in two control or test groups using the random block method. In this method, 6 sheets of paper are considered and letter A (test group) and another letter B (control group) are written on the sheet. In this method, There are 6 writing modes. The 6 leaves on which the above groups are written are mixed together and put aside inside the container. With each eligible patient's visit, a sheet is randomly picked by someone outside the study, and the task of 4 people is determined based on the selected sheet, and then the sheet is placed in the container. This means that the first 4 people who enter the research are placed in that group from left to right with the same order of letters. This method is repeated for the total number of patients needed for this study to complete the desired sample size.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients undergoing coronary artery bypass surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: When the patient is discharged from the inpatient department, the informed consent form and the clinical and demographic information questionnaire and the phone number are completed and received from the patient or the patient's companion. Then, according to the title of this study, which includes the third phase of cardiac rehabilitation, the next step of the study will be conducted in the period of 4 to 6 weeks after discharge from the hospital. In this study, the period of 5 weeks (45 days) after discharge in patients undergoing CABG will be the time to start virtual training for patients, the patients who have been included in the test group during sampling must complete the cardiovascular questionnaire after this 45-day period. This questionnaire was calculated with Cronbach's alpha coefficient of 80% in the research of Jafari Sajzi et al. (2017) after it was approved by 10 faculty members of Hamedan School of Nursing and Midwifery in terms of validity and reliability through an electronic file. It is sent to the patients and completed by the patient, and according to the time of entering the study, the researcher will join 7 groups of 10 people and 1 educational channel created by the researcher. Educational groups and channels are created on platforms accessible to patients, which were selected in the initial surveys of cardiac patients, because of their easy access and unlimited content uploading. The educational content according to the mentioned references and according to the titles included in the Esteka Cardiology Questionnaire for 1 month during 8 sessions (2 sessions per week) for 30 minutes based on the educational checklist created by the researcher in the form of video, audio, and written files in The platforms will be loaded. After each training session, feedback and educational follow-ups in the form of virtual or telephone conversations begin to evaluate the results of the training provided during the last week. After 75 days (45 days after discharge and after the completion of the one-month training period), the Esteka cardiology questionnaire was given to the study group again and using the electronic file sent to the groups by the patient or It will be completed with the patient. Data and results will be analyzed by SPSS23 software. It should be noted that the cost of internet consumption for the test group during this period will be provided by the researcher. Intervention 2: Control group: The patient's discharge time is completed from the section of the informed consent form and the phone number is received from the patient or the patient's companion. Then, according to the title of this study, which includes the third phase of cardiac rehabilitation, the next step of the study will be conducted in the period of 4 to 6 weeks after discharge from the hospital. In this study, the period of 5 weeks (45 days) after discharge in patients undergoing CABG will be the time to start virtual training for patients, after 45 days the Steka questionnaire must be completed by the control group. This questionnaire is calculated with Cronbach's alpha coefficient of 80% in The research of Jafari Sajzi et al. (2017) after it was approved by 10 faculty members of Hamedan Medical Sciences Faculty of Nursing and Midwifery in terms of validity and reliability, was sent to the patients through an electronic file and was completed by the patient. The patients who are placed in the control group with permutation block randomization will not receive the educational content that is provided to the test group during multiple sessions. And finally, without any other training and action, 75 days after the discharge (45 days after the discharge and the completion of the 1-month training period), the information questionnaire of Esteka will be provided to this group again through an electronic file through Rubika or ETA software. is given After completing all the questionnaires, data will be collected and SPSS23 software will be used for statistical analysis of the data. It should be noted that the intervention group will not be deprived of training during discharge, and after the completion of the study period, if the results of this research are effective, all training will be provided to the control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is After completing the research project and consulting with the professors, I will make a decision about this</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Amirlohesari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University Research and Technology Vice-Chancellor.، Hamedan University of Medical Sciences.، Shahid Fahmideh St.</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517838698</zip>
        <telephone>+98 81 3838 0447</telephone>
        <email>z.amirlohesari@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hiva Azami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University Research and Technology Vice-Chancellor.، Hamedan University of Medical Sciences., Shahid Fahmideh St</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517838698</zip>
        <telephone>+98 81 3838 0447</telephone>
        <email>hiva64@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The patient has recently undergone CABG
The patient should be willing to learn and participate in the study
Ability to use mobile platforms and have access to the Internet
The patient must be a resident of Hamadan province
Have a weak or moderate level of self-efficacy in primary results
The patient should have at least primary education
No mental illness or movement and learning limitations
The patient must consent to participate in the research
Be in the age range of 30 to 70 years</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The patient be over 80 years old
Participate in another educational program in the last 6 months
Have severe hearing and vision disorders
The patient is not literate</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>125.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Atherosclerotic heart disease of native coronary artery</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: When the patient is discharged from the inpatient department, the informed consent form and the clinical and demographic information questionnaire and the phone number are completed and received from the patient or the patient's companion. Then, according to the title of this study, which includes the third phase of cardiac rehabilitation, the next step of the study will be conducted in the period of 4 to 6 weeks after discharge from the hospital. In this study, the period of 5 weeks (45 days) after discharge in patients undergoing CABG will be the time to start virtual training for patients, the patients who have been included in the test group during sampling must complete the cardiovascular questionnaire after this 45-day period. This questionnaire was calculated with Cronbach's alpha coefficient of 80% in the research of Jafari Sajzi et al. (2017) after it was approved by 10 faculty members of Hamedan School of Nursing and Midwifery in terms of validity and reliability through an electronic file. It is sent to the patients and completed by the patient, and according to the time of entering the study, the researcher will join 7 groups of 10 people and 1 educational channel created by the researcher. Educational groups and channels are created on platforms accessible to patients, which were selected in the initial surveys of cardiac patients, because of their easy access and unlimited content uploading. The educational content according to the mentioned references and according to the titles included in the Esteka Cardiology Questionnaire for 1 month during 8 sessions (2 sessions per week) for 30 minutes based on the educational checklist created by the researcher in the form of video, audio, and written files in The platforms will be loaded. After each training session, feedback and educational follow-ups in the form of virtual or telephone conversations begin to evaluate the results of the training provided during the last week. After 75 days (45 days after discharge and after the completion of the one-month training period), the Esteka cardiology questionnaire was given to the study group again and using the electronic file sent to the groups by the patient or It will be completed with the patient. Data and results will be analyzed by SPSS23 software. It should be noted that the cost of internet consumption for the test group during this period will be provided by the researcher.</i_keyword>
      <i_keyword>Control group: The patient's discharge time is completed from the section of the informed consent form and the phone number is received from the patient or the patient's companion. Then, according to the title of this study, which includes the third phase of cardiac rehabilitation, the next step of the study will be conducted in the period of 4 to 6 weeks after discharge from the hospital. In this study, the period of 5 weeks (45 days) after discharge in patients undergoing CABG will be the time to start virtual training for patients, after 45 days the Steka questionnaire must be completed by the control group. This questionnaire is calculated with Cronbach's alpha coefficient of 80% in The research of Jafari Sajzi et al. (2017) after it was approved by 10 faculty members of Hamedan Medical Sciences Faculty of Nursing and Midwifery in terms of validity and reliability, was sent to the patients through an electronic file and was completed by the patient. The patients who are placed in the control group with permutation block randomization will not receive the educational content that is provided to the test group during multiple sessions. And finally, without any other training and action, 75 days after the discharge (45 days after the discharge and the completion of the 1-month training period), the information questionnaire of Esteka will be provided to this group again through an electronic file through Rubika or ETA software. is given After completing all the questionnaires, data will be collected and SPSS23 software will be used for statistical analysis of the data. It should be noted that the intervention group will not be deprived of training during discharge, and after the completion of the study period, if the results of this research are effective, all training will be provided to the control group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Self-efficacy. Timepoint: Before the intervention, 45 days and again 75 days after discharge from the hospital. Method of measurement: Using the Cardiovascular disease management Self-efficacy questionnaire of Esteka et al.: The Cardiovascular disease management Self-efficacy questionnaire was designed and compiled by Esteka et al. In (2015) in order to measure the Self-efficacy of Cardiovascular disease management. This questionnaire has 9 questions and 3 components of heart risk Self-efficacy,Treatment adherence Self-efficacy and symptom recognition Self-efficacy and based on the Likert spectrum with questions such as (you can avoid life Problems and Difficult situations and daily stress well) minimize) measures the Self-efficacy of Cardiovascular disease management. The Distribution of questionnaire questions is such that questions 1 to 4 examine the Self-efficacy of cardiac risk, questions 5 and 6 examine the Self-efficacy of following treatment, and questions 7, 8, and 9 examine the Self-efficacy of diagnosing symptoms.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-09-14</approval_date>
        <contact_name>Working group/committee of ethics in research of Hamadan University of Medical Sciences</contact_name>
        <contact_address>University Research and Technology Vice-Chancellor.، Hamedan University of Medical Sciences.، Shahid Fahmideh St Hamedan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
